Key result
Transcatheter Gerbode defect closure succeeds via femoral artery-jugular vein arteriovenous loop in high-risk surgery.
Why the study?
Transcatheter closure of acquired Gerbode defects after redo surgical AVR is pursued due to elevated surgical risk and prior sternotomies.
Case Report (n=1)
This case demonstrates the feasibility of maintaining an arteriovenous loop to facilitate transcatheter closure of an acquired Gerbode defect in high surgical risk patients.
Answers are grounded in this paper and cite their sources.
May offer bailout option for high-risk acquired Gerbode defects; leaves open durability, safety, and generalizability pending larger series.
A 78-year-old woman developed heart failure from an acquired Gerbode defect—a left ventricular outflow tract (LVOT)–right atrial (RA) shunt (Figure 1 panel 1A, 1B)—following a redo surgical aortic valve replacement (AVR) to explant a small Trifecta valve unsuitable for transcatheter valve-in-valve intervention. Transcatheter closure (TC) was pursued due to prior sternotomies and elevated surgical risk. An arteriovenous (AV) loop was established via the femoral artery and right internal jugular vein (Figure 1 panel 1C, Video) by crossing the defect from the LV side with a JR4 catheter and a 260 cm Terumo Glidewire into the right atrium, under fluoroscopic guidance with TEE confirmation, where it was snared from the right internal jugular (IJ) vein.
No takes yet. Share an insight, caveat, or question.
Alkasab et al. (2026) conducted a case report in Acquired Gerbode defect with heart failure (n=1). Transcatheter closure utilizing an arteriovenous loop was evaluated. Transcatheter closure of an acquired Gerbode defect was facilitated by establishing an arteriovenous loop via the femoral artery and right internal jugular vein in a high-risk surgical patient.
Synapse has enriched 10 related papers. Consider them for comparative context: